CX 2023 Full programme

Showing the latest CX 2023 Programme, talks, speakers and timings subject to change.

All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter the timings if necessary.

Day 1 Morning: Peripheral Arterial & Acute Limb Ischaemia & Randomised Control Trial Update - Tuesday, 25th April
Venue:   Kensington 1 / Livestream 1
Time: 08:00 - 13:00
Peripheral Arterial Consensus Update
Time: 08:00 - 09:40
Anchor:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Dittmar Boeckler, Heidelberg, Germany
08:00 - 08:05
Edited Case: Is transradial the new approach for peripheral artery treatment
Speaker:   Marianne Brodmann, Graz, Austria
08:05 - 08:10
Audience Participation & Discussion
08:10 - 08:15
SFA Intervention - What DES data suggest are best
Speaker:   Peter Schneider, San Francisco, United States
08:15 - 08:20
Audience Participation & Discussion
08:20 - 08:25
Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis
Speaker:   Marianne Brodmann, Graz, Austria
08:25 - 08:30
Audience Participation & Discussion
08:30 - 08:35
Edited Case: Optimising PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study
Speaker:   Michael Lichtenberg, Arnsberg, Germany
08:35 - 08:40
Audience Participation & Discussion
08:40 - 08:45
Directional atherectomy followed by drug-coated balloons to treat long, calcified femoropopliteal artery lesions: The REALITY study
Speaker:   Thomas Zeller, Bad Krozingen, Germany
08:45 - 08:50
Audience Participation & Discussion
08:50 - 08:55
Increasing supervised exercise therapy capacity for claudication without additional vascular resource: The advantage of integrating public health services into vascular clinical pathways
Speaker:   Naseer Ahmad, Manchester, United Kingdom
08:55 - 09:00
Audience Participation & Discussion
09:00 - 09:05
Edited Case: MIMICS-3D 3-year results: Compelling clinical outcomes in complex patients and lesions
Speaker:   Michael Lichtenberg, Arnsberg, Germany
09:05 - 09:10
Audience Participation & Discussion
09:10 - 09:15
Five-year outcomes of drug-coated balloon treatment for femoropopliteal artery disease: DCB safety and effectiveness across real-world subgroups / reintervention patterns among patients with in-stent restenosis, long lesions, and chronic total occlusions
Speaker:   Gunnar Tepe, Rosenheim, Germany
09:15 - 09:20
Audience Participation & Discussion
09:20 - 09:25
A patient-level pooled analysis of drug-coated balloons versus bare metal stents for the treatment of symptomatic femoropopliteal disease
Speaker:   Thomas Zeller, Bad Krozingen, Germany
09:25 - 09:30
Audience Participation & Discussion
09:30 - 09:35
Challenging the status quo of SFA treatment
Speaker:   Maarit Venermo, Helsinki, Finland
09:35 - 09:40
Audience Participation & Discussion
 
Sponsored Education
Time: 09:40 - 10:10
Coffee Break
Time: 10:10 - 10:30
Acute Limb Ischaemia Consensus Update
Time: 10:30 - 10:40
Anchor:   Roger Greenhalgh, London, United Kingdom
Moderator:   Gunnar Tepe, Rosenheim, Germany
10:30 - 10:35
Podium First: Primary endpoint results of the STRIDE trial on thrombectomy for acute limb ischemia
Speaker:   Sean Lyden, Cleveland, United States
10:35 - 10:40
Audience Participation & Discussion
 
Sponsored Education
Time: 10:40 - 11:10
Randomised Control Trial Consensus Update
Time: 11:10 - 13:00
BASIL-2 Podium First Presentation
Time: 11:10 - 13:00
Anchor:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Dittmar Boeckler, Heidelberg, Germany
Opening remarks and introduction
Speaker:   Andrew Bradbury, Birmingham, United Kingdom
The journey from BASIL-1 to BASIL-2
Speaker:   Lewis Meecham, Worcester, United Kingdom
Methodology: Statistical considerations
Speaker:   Catherine Moakes, Birmingham, United Kingdom
Methodology: Clinical considerations
Speaker:   Gareth Bate, Solihull, United Kingdom
Prospective cohort study: Putting BASIL-2 in context
Speaker:   Matthew Popplewell, Shrewsbury, United Kingdom
Limitations: Statistical considerations
Speaker:   Catherine Moakes, Birmingham, United Kingdom
Limitations: Clinical considerations
Speaker:   Andrew Bradbury, Birmingham, United Kingdom
Interpretation and future work
Speaker:   Andrew Bradbury, Birmingham, United Kingdom
11:40 - 13:00
Audience Participation & Roundtable Discussion
Anchor:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Dittmar Boeckler, Heidelberg, Germany
Discussant:   Jess Stonehouse, London, United Kingdom
Eleni Whatley, Silver Spring, United States
 
Lunch Break
Time: 13:00 - 13:30